Healthcare leads the charge with 3 stocks (AMGN, BMY, VRTX) recently rated strong buy by analysts on Tuesday. Energy names also gained traction with upgrades to PSX and GPOR. Average target price increases across the biotech sector suggest bullish momentum continues for large-cap names. However, a TSLA sell rating and ZS target cuts signal growing caution in high-valuation growth sectors.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.